Related Experiment Videos
[Ventricular function in hypertrophic cardiomyopathy. Systolic and diastolic ventricular function]
H G Olbrich1, M Kaltenbach, R Hopf
1Abteilung für Kardiologie, Universität Frankfurt.
Insights
Hypertrophic cardiomyopathy involves left ventricular hypertrophy without other causes, leading to symptoms like chest pain and shortness of breath. Impaired diastolic function and potential outflow tract obstruction characterize its hemodynamic profile.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease.
- Characterized by left ventricular hypertrophy without other cardiac or systemic causes.
- Key symptoms include exertional angina, dyspnea, fatigue, dizziness, and syncope.
Purpose:
- To define Hypertrophic Cardiomyopathy (HCM).
- To describe the clinical presentation and key symptoms.
- To elucidate the underlying pathophysiology and hemodynamic characteristics.
Summary:
- HCM presents as left ventricular hypertrophy, distinct from secondary causes.
- Hemodynamic findings include hyperdynamic systole and impaired diastolic function.
- Obstructive HCM involves basal septal hypertrophy and systolic anterior mitral motion, creating outflow tract gradients.
- Myocardial calcium metabolism disturbances are implicated in diastolic dysfunction.
Impact:
- Provides a clear definition and diagnostic criteria for HCM.
- Highlights the clinical significance of hemodynamic abnormalities in HCM.
- Suggests a potential molecular mechanism (calcium metabolism) for diastolic dysfunction in HCM.
Abstract:
BASIC CONSIDERATION: Hypertrophic cardiomyopathy is defined as a primary myocardial disease associated with a hypertrophic non-dilated left ventricle with no other heart or systemic disease that might lead to hypertrophy of the left ventricle. The leading symptoms are effort-associated angina and dyspnea, rapid fatigue, dizziness and syncope.
Main Points Discussed:
The hemodynamic situation is characterized by a hyperdynamic systole and impaired diastole and left-ventricular filling. In the obstructive form, hypertrophy of the basal septum and an anteriorly moving mitral valve during systole result in an end-systolic reduction in the cross-section of the outflow tract associated with considerable intraventricular pressure gradients. Disturbances in the myocardial calcium metabolism are presently suspected to be causally involved in the diastolic function impairment.